| Capecitabine investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 263show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 268 trials (50 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 268 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasmsubtype 194 trials (37 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasmcancer 120 trials (26 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 120 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Rectal Neoplasmcancer 116 trials (42 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Rectal Neoplasm | 116 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasm 93 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 50 trials (19 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 45 trials (23 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 40 trials (13 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastric Neoplasmcancer_family 37 trials (10 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastric Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasmcancer_family 37 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Colorectal Neoplasmsubtype 32 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Colorectal Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastric Adenocarcinoma 29 trials (17 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastric Adenocarcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colon Neoplasmcancer 29 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colon Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastroesophageal Junction Adenocarcinomasubtype 28 trials (12 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastroesophageal Junction Adenocarcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Esophageal Neoplasm 27 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Esophageal Neoplasm | 27 | Observed | clinicaltrials | graph → |